Hepatitis B virus reverse transcriptase — Drug Target

9 drugs 9 marketed

All drugs that target Hepatitis B virus reverse transcriptase — marketed and clinical-stage. Includes 5 drug classes acting on this target.

Drug classes

Nucleotide reverse transcriptase inhibitor · Nucleoside reverse transcriptase inhibitor (NRTI) · Nucleoside reverse transcriptase inhibitor · Nucleoside/nucleotide reverse transcriptase inhibitor · Nucleoside/nucleotide reverse transcriptase inhibitor (NRTI/NtRTI)

Marketed (9)